C-Reactive Protein (CRP) in Obese Diabetic Women

Interventions Study for the Control of Diabetes Mellitus Type 2 in Obese Women

The purpose of this study is to determine whether treatment with rosuvastatin for 6 months in obese type 2 diabetic women will improve their lipid profiles and thus prevent the progression to cardiovascular disease.

Inclusion Criteria:

• Menopausal
• Diagnosed diabetes mellitus type 2
• Obese (body mass index [BMI] > 25 ≤ 30)

Exclusion Criteria:

• Fasting blood glucose ≥ 200 mg/dl
• CRP < 2 mg/L and > 10 mg/L